Showing 1 - 7 results of 7 for search 'Donovan Flumens', query time: 0.04s Refine Results
  1. 1
    The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses

    The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses by Diana Campillo-Davo, Donovan Flumens, Eva Lion

    Published 2020-07-01
    Get full text
    Article
  2. 2
    One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation

    One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation by Donovan Flumens, Diana Campillo-Davo, Ibo Janssens, Gils Roex, Jorrit De Waele, Sébastien Anguille, Eva Lion

    Published 2023-03-01
    Get full text
    Article
  3. 3
    Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells

    Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells by Gils Roex, Diana Campillo-Davo, Donovan Flumens, Philip Anthony Gilbert Shaw, Laurens Krekelbergh, Hans De Reu, Zwi N. Berneman, Eva Lion, Sébastien Anguille

    Published 2022-03-01
    Get full text
    Article
  4. 4
    The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy

    The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy by Diana Campillo-Davo, Maxime De Laere, Gils Roex, Maarten Versteven, Donovan Flumens, Zwi N. Berneman, Viggo F. I. Van Tendeloo, Sébastien Anguille, Eva Lion

    Published 2021-03-01
    Get full text
    Article
  5. 5
    Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma

    Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma by Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi N. Berneman, Eva Lion, Feifei Luo, Sébastien Anguille

    Published 2020-12-01
    Get full text
    Article
  6. 6
    In vitro expansion of Wilms’ tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells

    In vitro expansion of Wilms’ tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells by Sanne van der Heijden, Donovan Flumens, Maarten Versteven, Stefanie Peeters, Hans De Reu, Diana Campillo-Davo, Yannick Willemen, Benson Ogunjimi, Viggo Van Tendeloo, Zwi N. Berneman, Sébastien Anguille, Evelien Smits, Eva Lion

    Published 2023-03-01
    Get full text
    Article
  7. 7
    Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands

    Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands by Maarten Versteven, Donovan Flumens, Diana Campillo-Davó, Hans De Reu, Laura Van Bruggen, Stefanie Peeters, Viggo Van Tendeloo, Zwi Berneman, Zwi Berneman, Zwi Berneman, Harry Dolstra, Sébastien Anguille, Sébastien Anguille, Sébastien Anguille, Willemijn Hobo, Evelien Smits, Evelien Smits, Eva Lion, Eva Lion

    Published 2022-02-01
    Get full text
    Article

Search Tools: